Performance
Trailing returns
| 1 day |
| -0.42% | |||
| 1 week | +0.00% | ||||
| 4 week | +2.64% |
| |||
| 3 month | +4.99% |
| |||
| YTD | +8.40% |
| |||
| 1 year | +19.42% |
| |||
| 3 years* | +11.78% |
| |||
| 5 years* | +5.78% |
| |||
| *annualized | |||||
| Best 3 month return | +21.84% | |
| Worst 3 month return | -29.98% |
Morningstar statistics
Morningstar category: Conservative Allocation
| Return | Risk | Rating | |
| 3 years | Above Average | High |
 
|
| 5 years | Average | High |
|
| 10 years | High | High |
|
| Overall | Above Average | High |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 77.75B | |
| Front load | 4.25% | |
| Deferred load | - | |
| Expense ratio | 0.64% | |
| Management fee | - | |
| Fund family | Franklin Templeton Investment Funds |
Asset allocation
| Cash | 2.76% | |
| Stocks | 45.92% | |
| Bonds | 37.24% | |
| Preferred | 11.64% | |
| Convertible | 0.32% | |
| Other | 2.12% |
Purchase information
| Initial | $1,000 | |
| IRA Initial | $250 | |
| AIP Initial | $50 | |
| AIP Additional | $50 |
2.38+0.01(0.42%)
May 17, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks to maximize income while maintaining prospects for capital appreciation. The fund invests in a diversified portfolio of debt and equity securities. The equity securities in which the fund invests consist primarily of common stocks. Debt securities include all varieties of fixed, floating and variable rate instruments, including secured and unsecured bonds, bonds convertible into common stock, senior floating rate and term loans, mortgage-backed securities and other asset-backed securities, debentures, and shorter term instruments. It may invest up to 100% of its total assets in debt securities that are rated below investment grade.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Matthew Quinlan (Started: Dec 21, 2012)
Edward Perks (Started: May 1, 2002)
Alex Peters (Started: Dec 21, 2012)
Charles Johnson (Started: Dec 21, 2012)
Matthew Quinlan (Started: Dec 21, 2012)
Edward Perks (Started: May 1, 2002)
Alex Peters (Started: Dec 21, 2012)
Charles Johnson (Started: Dec 21, 2012)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 5.37 | 1.72 | 0.51 | 0.08 | |
| Beta* | 0.95 | 0.96 | 1.10 | 1.08 | |
| Mean annual return | 1.28 | 0.87 | 0.58 | 0.76 | |
| R-squared* | 84.23 | 89.34 | 85.83 | 83.04 | |
| Standard deviation | 7.24 | 9.91 | 14.86 | 11.51 | |
| Sharpe ratio | 2.10 | 1.04 | 0.45 | 0.64 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Merck & Co Inc (MRK) | 2.09% | |
| General Electric Co (GE) | 1.53% | |
| Wells Fargo & Co (WFC) | 1.51% | |
| Exelon Corp (EXC) | 1.37% | |
| Duke Energy Corporation (DUK) | 1.35% | |
| Texas Competitive Electric Hol | 1.33% | |
| Johnson & Johnson (JNJ) | 1.30% | |
| Jpmorgan Chase FRN | 1.24% | |
| BP PLC ADR (BP) | 1.23% | |
| Roche Holding AG (RHHVF) | 1.23% |